AT-Patch (ATP-C130/ATP-C70) vs Affiniti Series Diagnostic Ultrasound Systems

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AT-Patch (ATP-C130/ATP-C70)

by ATsens Co.

Affiniti Series Diagnostic Ultrasound Systems

by Philips Ultrasound

AI Verdict

Tool A, the AT-Patch, is a wearable ECG monitor designed for continuous cardiac electrical activity monitoring and AI-powered arrhythmia detection. In contrast, Tool B, the Philips Affiniti Series, is a diagnostic ultrasound system focused on advanced imaging for structural and functional assessment of the heart and other organs. While both leverage AI in cardiology, they address different diagnostic needs, making them complementary rather than direct competitors.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if you require extended, continuous cardiac monitoring for patients in an ambulatory setting. Its lightweight, shower-proof design and up to 14 days of monitoring are ideal for detecting intermittent arrhythmias without significantly disrupting a patient's daily life, supported by integrated AI-powered analysis for efficient detection.

View AT-Patch (ATP-C130/ATP-C70) →

Choose Affiniti Series Diagnostic Ultrasound Systems if…

Choose Philips Affiniti Series if your clinical practice needs a versatile, high-performance diagnostic ultrasound system for real-time imaging across multiple specialties such as cardiology, OB/GYN, and radiology. Its advanced features, including PureWave technology and Anatomical Intelligence, provide excellent image quality and efficient workflows for confident and reproducible diagnoses within a clinical environment.

View Affiniti Series Diagnostic Ultrasound Systems →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AT-Patch (ATP-C130/ATP-C70)	Affiniti Series Diagnostic Ultrasound Systems
Pricing	N/a	Varies by model and condition (new/refurbished). generally considered a 'mid tier' or 'budget' shared service ultrasound with rich image quality at an affordable price point compared to premium models.
Deployment	Wearable device for patients; analysis software deployed on-premise at medical institutions.	On-premise (console hardware system)
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AT-Patch (ATP-C130/ATP-C70)

AT-Patch (Tool A) is designed for patient comfort and ease of use, being a compact, shower-proof wearable that requires no charging during its 14-day monitoring period. Its accompanying smartphone app allows for live ECG viewing, making it highly accessible for the end-user. In contrast, the Philips Affiniti Series (Tool B) is a complex console system requiring trained medical professionals to operate.

Clinical Value

Tie

Both tools offer significant clinical value in their respective domains. AT-Patch provides crucial long-term continuous ECG monitoring with AI for enhanced arrhythmia detection, addressing a key need in cardiology. The Philips Affiniti Series delivers advanced diagnostic ultrasound imaging across multiple specialties, enabling confident diagnosis for a wide range of conditions. Their distinct applications make a direct comparison of overall clinical value difficult.

Pricing & Value

Affiniti Series Diagnostic Ultrasound Systems

The Philips Affiniti Series (Tool B) provides specific pricing ranges for refurbished models, offering a degree of transparency regarding its market value. AT-Patch (Tool A) has no publicly available pricing information, stating it involves direct sales to medical institutions, which makes it less transparent for comparison. While both offer value, Tool B's pricing transparency gives it an edge in this dimension.

Enterprise Readiness

Affiniti Series Diagnostic Ultrasound Systems

The Philips Affiniti Series (Tool B) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, which are critical for enterprise deployment in healthcare. AT-Patch (Tool A) only states HIPAA compliance is 'likely' and does not explicitly mention a BAA. This makes Tool B more clearly positioned for enterprise-level integration and compliance.

Innovation

Affiniti Series Diagnostic Ultrasound Systems

While AT-Patch (Tool A) innovates with AI-powered arrhythmia detection in a patient-friendly wearable, the Philips Affiniti Series (Tool B) showcases a broader range of advanced imaging technologies. Its features like PureWave crystal technology, Anatomical Intelligence Ultrasound (AIUS), xMatrix transducers, and various elastography and flow imaging techniques represent significant innovation across multiple facets of diagnostic imaging.

Support & Docs

Affiniti Series Diagnostic Ultrasound Systems

As a global medical device giant, Philips (Tool B) is expected to have a more robust and extensive support infrastructure, including comprehensive documentation, training resources, and dedicated customer service for its complex ultrasound systems. While ATsens (Tool A) likely offers support for its wearable device, the breadth and depth of support and documentation from a large, established company like Philips are generally superior.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AT-Patch (ATP-C130/ATP-C70)	Affiniti Series Diagnostic Ultrasound Systems
Product Type	FDA-cleared wearable ECG monitor for continuous cardiac monitoring	Diagnostic Ultrasound Systems for advanced imaging
Company	ATsens Co.	Philips Ultrasound
Tagline	Ambulatory ECG Monitor for Continuous Cardiac Monitoring	Designed for everyday ultrasound workflow, delivering diagnostic confidence and reproducibility.
Primary Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology, Obstetrics & Gynecology, Radiology
Key Features (Examples)	Up to 14 days of continuous ECG monitoring, Shower-proof design, AI/machine learning algorithms for ECG analysis.	PureWave crystal technology, Anatomical Intelligence Ultrasound (AIUS), xMatrix transducer technology.

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and Affiniti Series Diagnostic Ultrasound Systems.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications for each tool?

The AT-Patch is designed for continuous cardiac monitoring, offering up to 14 days of ECG recording with AI-powered analysis for enhanced arrhythmia detection. The Philips Affiniti Series Diagnostic Ultrasound Systems provide advanced imaging for diverse clinical needs, including cardiology, obstetrics & gynecology, and radiology, focusing on diagnostic confidence and reproducibility.

How do the AI capabilities differ between the AT-Patch and the Affiniti Series?

The AT-Patch utilizes AI/machine learning algorithms within its AT-Report software for ECG analysis and enhanced arrhythmia detection. The Philips Affiniti Series incorporates Anatomical Intelligence Ultrasound (AIUS) and NextGen Auto Scan for adaptive image optimization and efficient workflows across its diagnostic imaging applications.

What is the patient experience like with each device?

Patients wear the AT-Patch, a compact, lightweight (13g), and shower-proof device for up to 14 days of continuous monitoring, with an optional smartphone app for live ECG viewing and symptom recording. The Philips Affiniti Series is an on-premise console hardware system used by clinicians for diagnostic imaging, meaning patients undergo an in-office procedure rather than wearing a device.

How do the data compliance and security features compare?

Both tools are FDA-cleared and operate within the US healthcare system. The AT-Patch is likely HIPAA compliant, while the Philips Affiniti Series explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA).

What are the key differences in monitoring or diagnostic duration and capabilities?

The AT-Patch offers continuous ECG monitoring for up to 14 days, specifically for arrhythmia detection. The Philips Affiniti Series provides real-time diagnostic ultrasound imaging for a wide range of applications, including cardiac, OB/GYN, and radiology, with various imaging modes and elastography capabilities.